Regeneron Pharmaceuticals, Inc.
Anti-VEGF protein compositions and methods for producing the same

Abstract:

The present disclosure pertains to compositions comprising aflibercept and methods for producing such compositions in chemically defined media and using chromatography to reduce amounts of certain aflibercept variants.